RecruitingNot ApplicableNCT05486546

Contoura With Phorcides Compared to Wavefront Optimized LASIK

Comparison of Visual Acuity and Quality of Life Following Contoura With Phorcides Compared to WaveLight Wavefront Optimized LASIK

Sponsor

Daniel Terveen

Enrollment

120 participants

Start Date

Aug 15, 2022

Study Type

INTERVENTIONAL

Conditions

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

Min Age: 21 YearsMax Age: 38 Years

Patients at least age 21 years of age undergoing LASIK eye surgery
Willing and able to comprehend informed consent and complete 1 month post-op visit
Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion
Candidates for Contoura with Phorcides (Myopic, astigmatism <3.0D)
Both eyes targeted for plano
Pre-operative total corneal Pachymetry 490um or above
Stable refractive error <0.50D change in preceding year
Good general and ocular health
Pre-operative exam completed within three months of surgery
SCL discontinued 3 days prior to pre-op exam and the procedure
Pachymetry above 490 with residual greater than 270um
Candidates who, as determined by the investigator, can safely undergo LASIK

Patients under 21 years of age
Concomitant ocular condition which would limit the BCVA at the discretion of the surgeon
Patients with usual relative and absolute contraindications for LASIK surgery (Patients with severe dry eye, recurrent corneal erosion, uncontrolled Glaucoma, collagen vascular disorders, keratoconus or signs of keratoconus, uncontrolled Diabetes, Herpes)
Pachymetry below 490
Autoimmune or immunodeficiency diseases
Pregnant or nursing women
Patients with signs of inability to understand consent for study and procedure planned
Patients with history of previous ocular surgery
Patients with strabismus or amblyopia
Patients that have a BCDVA of 20/25 or worse in either eye